Amgen is integrating artificial intelligence into its clinical development processes to accelerate drug discovery and improve trial efficiency. The company is exploring AI for tasks such as identifying patient cohorts, optimizing trial design, and analyzing complex biological data. This strategic adoption aims to bring new therapies to patients faster and more effectively. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Accelerates drug discovery timelines and enhances clinical trial efficiency through AI integration.
RANK_REASON The cluster discusses the application of AI within a company's existing processes, not a new AI product or core AI research.
